Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sensei Biotherapeutics

Sensei Biotherapeutics?uq=kzBhZRuG
1999 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series E LATEST DEAL TYPE
$15M LATEST DEAL AMOUNT
17 INVESTORS
Description

Operator of a biotechnology company designed to discover, develop and commercialize innovative therapeutic and diagnostic products. The company's therapeutic and diagnostic products include cancer vaccine and radio-immune-imaging test that targets a novel patented tumor marker and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, enabling healthcare professionals to treat cancer and diseases of the central nervous system.

Formerly Known As
Panacea Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Biotechnology
Primary Office
  • 209 Perry Parkway
  • Suite 13
  • Gaithersburg, MD 20877
  • United States

+1 (240) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sensei Biotherapeutics’s full profile, request a free trial.

Sensei Biotherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 08-Dec-2015 $15M 000.00 Completed Clinical Trials - Phase 1
6. Later Stage VC 31-Mar-2007 00000 000.00 Completed Pre-Clinical Trials
5. Later Stage VC (Series D) 12-Jun-2006 00.00 000.00 Completed Pre-Clinical Trials
4. Corporate (Series C) 08-Jul-2005 000 0000 Completed Pre-Clinical Trials
3. Corporate (Series B) 01-May-2002 000 000 Completed Startup
2. Angel (individual) 27-Sep-2000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sensei Biotherapeutics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SoftBank Capital Corporate Venture Capital Minority 000 0000 000000 0
Kenso Kogyo Other Minority 000 0000 000000 0
Konishi Hiroshi Angel (individual) Minority 000 0000 000000 0
Kyokuto Securities Company Other Minority 000 0000 000000 0
Medikit Company Corporation Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Sensei Biotherapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
John Celebi President & Chief Executive Officer
Hossein Ghanbari Ph.D Co-Founder, Chief Scientific Officer & Chairman
Steve Fuller Ph.D Chief Operating Officer
Kasra Ghanbari Co-Founder & Special Consultant

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Sensei Biotherapeutics Board Members (7)

Name Representing Role Since Contact
Info
Eiichi Ida Self Board Member 000 0000
Hossein Ghanbari Ph.D Sensei Biotherapeutics Co-Founder, Chief Scientific Officer & Chairman 000 0000
Mark Ford Ph.D Self Board Member 000 0000
Mehdi Hatamian Ph.D Self Board Member 000 0000
Robert Holmen JD Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »